Level Biotechnology Capital Reinvestment Ratio
Level Biotechnology capital reinvestment ratio. Level Biotechnology (3118) has a Capital Reinvestment Ratio of 0.38x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$11.81 Million) in capital expenditures (NT$4.44 Million). Check 3118 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Level Biotechnology (2017–2024)
Capital reinvestment ratio of Level Biotechnology from 2017 to 2024. This chart tracks Level Biotechnology's Capital Reinvestment Ratio across 8 annual periods. Also explore 3118 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Level Biotechnology Capital Reinvestment Ratio by Year (2017–2024)
Level Biotechnology capital reinvestment ratio by year from 2017 to 2024. For the full cash flow conversion analysis, see 3118 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 3.49x | NT$64.10 Million | NT$223.68 Million | ▲ +3095.2% |
| 2023 | 0.11x | NT$70.21 Million | NT$7.67 Million | ▲ +5.5% |
| 2022 | 0.10x | NT$65.07 Million | NT$6.74 Million | ▲ +76.4% |
| 2021 | 0.06x | NT$155.95 Million | NT$9.15 Million | ▲ +92.3% |
| 2020 | 0.03x | NT$83.23 Million | NT$2.54 Million | ▲ +37.2% |
| 2019 | 0.02x | NT$109.02 Million | NT$2.43 Million | ▼ -76.3% |
| 2018 | 0.09x | NT$26.77 Million | NT$2.51 Million | ▼ -38.2% |
| 2017 | 0.15x | NT$71.29 Million | NT$10.83 Million | — |